Question 15174 — maternity health insurance

Summary

Mr. Jean-Pierre Door draws the attention of the Minister of Solidarity and Health to the dereimbursement of symptomatic treatments prescribed to people suffering from Alzheimer's disease or a related disease which came into force on August 1, 2018. Four medications can be prescribed to people suffering from Alzheimer's disease or a related disease. Taking these medications, combined with other methods of taking care, helps limit the impact of loss of autonomy and promote the well-being of the patient and those around them. Their dereimbursement has consequences, sometimes disastrous, for the people directly concerned. Families who can no longer afford such treatments notice, after stopping them, a precipitous worsening of the patients' cognitive and behavioral disorders. When they try to maintain the taking medication, families are then faced with a direct increase in their out-of-pocket costs of several hundred euros per year. In the absence of curative treatment and despite 100% coverage of the disease within the framework of the list of pathologies recognized as long-term conditions, 70% of the expenses incurred fall within the medico-social sector and are thus mainly borne by the families. The dereimbursement thus has the effect of putting in place a two-tier system of care. On the other hand, taking these treatments was until now a condition of access to clinical trials and thus represented an opportunity for all French patients to access innovative therapies. This decision therefore has a negative impact on the continuation of tests on potential new molecules and more. generally on national competitiveness. Faced with a difficulty affecting the daily lives of thousands of people in France, he asks what decisions the Government intends to take to sustainably improve the care of sick people and the support of their caregivers.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.